The latest report by IMARC Group, titled “Radiotherapy Market Report by Type (External Beam Radiation Therapy, Internal Radiation Therapy/Brachytherapy, Systemic Radiation Therapy), Application (Skin and Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, and Others), End User (Hospitals, Cancer Research Institutes, Ambulatory and Radiotherapy Centers), and Region 2024-2032“, The global radiotherapy market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.
Factors Affecting the Growth of the Radiotherapy Industry:
- Significant Technological Advancements:
One of the primary factors driving the radiotherapy market is technological advancements. Innovations such as Intensity-Modulated Radiotherapy (IMRT), Image-Guided Radiotherapy (IGRT), Stereotactic Body Radiotherapy (SBRT), and proton therapy have significantly improved the precision, effectiveness, and safety of radiotherapy treatments. These advanced techniques allow for higher doses of radiation to be delivered to tumors with minimal damage to surrounding healthy tissues. IMRT, for instance, uses computer-controlled linear accelerators to deliver precise radiation doses that conform to the shape of the tumor. IGRT incorporates imaging techniques during treatment to enhance accuracy, ensuring the radiation beam targets the tumor accurately even if it moves between treatments. SBRT is designed to deliver very high doses of radiation to small, well-defined tumors in a short time frame, often in just a few sessions. Proton therapy, utilizing protons instead of X-rays, allows for even greater precision and is especially beneficial for treating tumors in sensitive areas such as the brain and spine. These advancements improve patient outcomes and also reduce side effects, making radiotherapy a more attractive option for both patients and healthcare providers.
- Rising Incidence of Cancer:
The increasing prevalence of cancer worldwide is another significant factor propelling the growth of the radiotherapy market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality globally, with an estimated 19.3 million new cases and 10 million deaths in 2020. Factors contributing to this rising incidence include aging populations, lifestyle changes, and environmental factors. As the number of cancer patients continues to rise, so does the demand for effective treatment options such as radiotherapy. Radiotherapy plays a crucial role in cancer management, either as a standalone treatment or in combination with surgery and chemotherapy. It is estimated that about 50% of all cancer patients could benefit from radiotherapy at some point during their treatment. This high demand underscores the necessity for continued investment and innovation in radiotherapy technologies and infrastructure. Healthcare systems worldwide are expanding their radiotherapy capacities to meet this growing need, further driving market growth.
- Increasing Healthcare Expenditure:
Growing healthcare expenditure, particularly in developing economies, is a crucial driver for the radiotherapy market. As countries invest more in their healthcare infrastructure, there is an increased emphasis on improving cancer treatment facilities, including radiotherapy centers. Governments and private sectors are allocating substantial funds to upgrade existing radiotherapy equipment and build new centers equipped with the latest technologies. For instance, many countries in Asia, Latin America, and Africa are witnessing rapid economic growth, which translates into higher healthcare budgets. This investment enhances access to advanced cancer treatments and also drives market growth by boosting the adoption of cutting-edge radiotherapy technologies. Additionally, increased healthcare spending often comes with initiatives to improve healthcare accessibility and affordability, making advanced radiotherapy treatments available to a broader population. Public awareness campaigns and government-supported health insurance schemes also play a role in encouraging more patients to seek radiotherapy treatments, thereby expanding the market.
Competitive Landscape with Key Player:
- Accuray Incorporated
- Becton Dickinson and Company
- Eckert & Ziegler
- Elekta AB (publ)
- General Electric Company
- Hitachi Ltd
- Ion Beam Applications
- Isoray Inc.
- Mevion Medical Systems Inc.
- Nordion Inc. (Sotera Health)
- Siemens Healthineers AG (Siemens AG)
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/radiotherapy-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- External Beam Radiation Therapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- Tomotherapy
- Stereotactic Radiosurgery
- Stereotactic Body Radiation Therapy
- Proton Therapy
- 3D Conformal Radiotherapy (3D CRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Internal Radiation Therapy/Brachytherapy
- Systemic Radiation Therapy
External beam radiation dominates the market due to its widespread use and versatility in treating various types of cancers with precise, targeted doses of radiation from outside the body.
Breakup by Application:
- Skin and Lip Cancer
- Head and Neck Cancer
- Breast Cancer
- Prostate Cancer
- Cervical Cancer
- Lung Cancer
- Others
Breast cancer holds maximum number of shares due to its high prevalence and the extensive use of radiotherapy as a critical component of treatment protocols to reduce recurrence and improve survival rates.
Breakup by End User:
- Hospitals
- Cancer Research Institutes
- Ambulatory and Radiotherapy Centers
Ambulatory and radiotherapy centers represent the largest segment due to its cost-effectiveness, convenience, and ability to deliver advanced, precise treatments without the need for extended hospital stays.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the radiotherapy market is attributed to its advanced healthcare infrastructure, high prevalence of cancer, and significant investment in cutting-edge radiotherapy technologies.
Global Radiotherapy Market Trends:
Favorable reimbursement policies in North America significantly drive the radiotherapy market. In the United States, Medicare and private health insurance companies often cover a substantial portion of radiotherapy costs, making these treatments more accessible to patients. These reimbursement schemes alleviate the financial burden on patients, encouraging them to opt for radiotherapy as a viable treatment option. The comprehensive coverage provided by these policies also supports the adoption of advanced radiotherapy technologies, as healthcare providers are more likely to invest in high-cost, cutting-edge equipment knowing that the treatments will be reimbursed. This financial support stimulates market growth by ensuring that more patients can afford and access high-quality radiotherapy services, ultimately leading to better treatment outcomes and increased demand.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
